Skip to main content

Silverstein Christine Berni

In the past year, 2 open-market sale filings worth $205.8K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$205.8K
2 filings
Net
−$205.8K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Silverstein Christine Berni as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ABEO Abeona Therapeutics Inc.

Director5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 15, 2026 (view filing)Jun 15Same daySilverstein Christine BerniDirectorSSale−18.2K$5.71−$103.7K−13.2%119.6K after
Feb 4, 2026 (view filing)Feb 22 daysSilverstein Christine BerniDirectorSSale−20.1K$5.09−$102.2K−12.7%137.7K after
Jul 10, 2025 (view filing)Jul 91 daySilverstein Christine BerniDirectorSSale−13.1K$5.86−$76.7K−9.8%120.5K after
Jun 20, 2024 (view filing)Jun 182 daysSilverstein Christine BerniDirectorSSale−25.8K$4.51−$116.5K−29.4%62.1K after
Sep 29, 2023 (view filing)Sep 272 daysSilverstein Christine BerniDirectorSSale−6.33K$3.91−$24.8K−6.7%87.9K after